Nissei Capital
VC Fund
Tokyo, Japan
Nissei Capital is a VC fund in Tokyo focused on Software and Health Care. Nissei Capital, a Japanese investment company, offers early- and later-stage venture investment services and solutions.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Nissei Capital invests in
Stages Nissei Capital invests in
Countries Nissei Capital invests in
Investment Focus
Industry
- Software 2 (29%)
- Health Care 2 (29%)
- Information Technology 2 (29%)
- CRM 1 (14%)
- SaaS 1 (14%)
Stage
- Series A 3 (43%)
- Series B 2 (29%)
- Seed 1 (14%)
- Series C 1 (14%)
Country
- Japan 5 (71%)
- United States 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Wevnal is a technology and information service platform. The company provides services that include chatbot development, video production, and advertising. Their customers' inquiries are addressed through phone, email, and online applications. | $5.5M / Series A / Sep 22, 2021 | ||
| Smart119, a medical & IT company, was founded by the Professor and Chairman of National Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine. Smart119's mission is to improve emergency and critical care by computer science and artificial intelligence. | $2.8M / Series B / Aug 10, 2021 | ||
| Smart119, a medical & IT company, was founded by the Professor and Chairman of National Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine. Smart119's mission is to improve emergency and critical care by computer science and artificial intelligence. | $12.9M / Series A / Aug 23, 2019 | ||
| Matsurika develops and provides the sales and marketing platform "Senses" that maximizes the results of the sales organization. Rather than aiming for simple efficiency by combining the power of people and technology, it will create a more free, more creative, and fulfilling work life in the world. | $18.4M / Series A / Aug 21, 2017 | ||
| CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment ofosteoarthritisThe company was founded in 2001 and is headquartered in Tokyo, Japan. | $115.9M / Seed / Nov 02, 2005 | ||
| Mountain View Data, Inc. delivers cluster server management software and advanced storage software. Top-tier server manufacturers, telecomm leaders and system integrators in Asia and the United States are integrating Mountain View Data software into their network storage products and services. Mountain View Data was established in October 2000, andhas offices in San Francisco, Tokyo and Beijing. Mountain View Data's products deliver performance and scalability, while enabling system integrators, xSPs, and Internet data centers worldwide to use commodity-based hardware components that lower ownership costs. | Series B / Apr 02, 2003 | ||
| HENNGE is a leading cloud IDaaS provider based in Japan. Its name has changed from HDE, Inc. since Feb 2019. | Series C / Feb 14, 2001 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Nissei Capital invest in?
Nissei Capital invests primarily in Software, Health Care and Information Technology startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nissei Capital last invest?
The most recent investment recorded for Nissei Capital closed in Sep 2021. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
